Dr. Kathy D. Miller, MD

Dr. Miller practices at IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health.

Dr. Miller's NPI, 1649236043, was assigned on April 25, 2006. Dr. Miller holds Indiana license 01042335.

Dr. Miller's primary practice is IU Health Methodist Hospital, at 1701 N Senate Blvd, Indianapolis, IN 46202 in Marion County. The practice phone is (317) 962-2000.

Dr. Miller's primary practice is IU Health Methodist Hospital in Indianapolis, Indiana, part of Indiana University Health. Dr. Miller is also affiliated with Sidney & Lois Eskenazi Hospital. The medical group on file is IU Health Medical Group. Dmand AI also links Dr. Miller to 2 more hospitals, 2 group practices and clinics, 1 behavioral health center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Miller practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Miller's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Miller is licensed in Indiana.

CMS data shows 348 Medicare services from Dr. Miller across 2 procedure codes in 2024, all of them office visits, for 217 Medicare patients. Medicare paid $17,289 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 217 Medicare patients who saw Dr. Miller in 2024. The largest group is 65 to 74, with 115 patients. 75% of them have cancer, and 69% have high blood pressure. 21% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Miller's median patient age at 63, with 98% women.

In 2024, Dr. Miller wrote 1,208 Medicare Part D claims for 251 patients. 85% of them were for generic drugs. CMS names the drug for 1,065 of them, across 25 drugs with 11 or more claims each, at $2,029,459 in total drug cost. In 2023, CMS named 1,148 claims across 26 drugs.

Dr. Miller accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 83 general payments to Dr. Miller from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 85% of the total. Merck Sharp & Dohme Corporation paid the most, $37,170. It also lists 2 research payments totaling $3,804 from 2016 to 2023.